Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$34,000.00

Targeting Pathogens at the Site of Cellular Entry

EF 2012-13

Résumé
The long term objective of this research is to develop a novel therapeutic approach that will revolutionize the way transmissible diseases are treated, by offering an alternative therapy to antiviral drugs, antibiotics and vaccines. Brucellosis and tuberculosis, for which there are no cures or treatments, are major infectious agents in wild and domestic species. Furthermore, animals are major sources of infectious diseases to other animals and humans. Brucellosis is a zoonosis transmitted by direct animal-to-human contact. Other zoonoses include Leihsmania donovani, H5N1 avian influenza virus and HIV virus. Cross-species viral and bacterial infections are a constant preoccupation with respect to iatrogenic enhancement due to cross-species transmission and antibiotic resistance. It is well known that the majority of pathogens invade the cell via endocytosis, by attaching to existing cell surface receptors. Inside the cell, the pathogens trick the endosomes and lysosomes and preferentially divide within them. In eukaryotic cells the delivery of newly synthesized proteins to endosomes and lysosomes is dependent on the Golgi apparatus, i.e. the organelle that sorts and targets proteins to these destinations. Proteins delivered to endosomes and lysosomes include enzymes and activator proteins. They are directed therein via special sorting receptors. Recently, we identified a region in the lysosomal protein prosaposin that contains a motif required for its binding to the sorting receptors sortilin and consequently for its transport to endosomes and lysosomes. In this proposal we will test the hypothesis that fusion proteins linked to this motiff can be transported to the endo/lysosomal compartment via sortilin, and that this sequence may be useful for the targeting of anti-pathogenic proteins. Our study will permit to establish a proof of concept of a new strategy for the targeting of antimicrobial proteins to the endo/lysosomal compartment. The outcome of our research will be relevant for the treatment of infectious diseases in wild, endangered, and domestic animal species, as well as in humans, and will open innumerable avenues to examine the delivery and effects of antipathogenic peptides in viral, bacterial and protozoal infections.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
183639-2012
Name nom
Morales, Carlos
Department département
Anatomy and Cell Biology
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
5
Application title
Targeting Pathogens at the Site of Cellular Entry
Keyword
NSERC
Application summary
The long term objective of this research is to develop a novel therapeutic approach that will revolutionize the way transmissible diseases are treated, by offering an alternative therapy to antiviral drugs, antibiotics and vaccines. Brucellosis and tuberculosis, for which there are no cures or treatments, are major infectious agents in wild and domestic species. Furthermore, animals are major sources of infectious diseases to other animals and humans. Brucellosis is a zoonosis transmitted by direct animal-to-human contact. Other zoonoses include Leihsmania donovani, H5N1 avian influenza virus and HIV virus. Cross-species viral and bacterial infections are a constant preoccupation with respect to iatrogenic enhancement due to cross-species transmission and antibiotic resistance. It is well known that the majority of pathogens invade the cell via endocytosis, by attaching to existing cell surface receptors. Inside the cell, the pathogens trick the endosomes and lysosomes and preferentially divide within them. In eukaryotic cells the delivery of newly synthesized proteins to endosomes and lysosomes is dependent on the Golgi apparatus, i.e. the organelle that sorts and targets proteins to these destinations. Proteins delivered to endosomes and lysosomes include enzymes and activator proteins. They are directed therein via special sorting receptors. Recently, we identified a region in the lysosomal protein prosaposin that contains a motif required for its binding to the sorting receptors sortilin and consequently for its transport to endosomes and lysosomes. In this proposal we will test the hypothesis that fusion proteins linked to this motiff can be transported to the endo/lysosomal compartment via sortilin, and that this sequence may be useful for the targeting of anti-pathogenic proteins. Our study will permit to establish a proof of concept of a new strategy for the targeting of antimicrobial proteins to the endo/lysosomal compartment. The outcome of our research will be relevant for the treatment of infectious diseases in wild, endangered, and domestic animal species, as well as in humans, and will open innumerable avenues to examine the delivery and effects of antipathogenic peptides in viral, bacterial and protozoal infections.